2 September 2018 (Sunday) |
|||||
| PROGRAMME (SYMPOSIUM ON ASTHMA AND COPD - NOW AND FUTURE) | |||||
| 08:00 - 08:30 |
Registration (Foyer of Meeting Room S421) |
||||
| MEETING ROOM S421 | |||||
| 08:30 - 10:00 | Symposium 3: Managing severe asthma: what’s new? A practical approach to assessment and management of difficult-to-treat asthma Helen Reddel (Australia) Treating type 2- high asthma Ian Pavord (UK) Treating non-eosinophilic asthma Ratko Djukanovic (UK) Bronchial Thermoplasty Mario Castro (USA) | ||||
| 10:00 - 10:30 | Tea Break and Exhibition | ||||
| 10:30 - 12:00 | Symposium 4: New developments in COPD Measurement of bronchodilator responses in COPD: forced oscillation and imaging Gregory King (Australia) Personalised therapy of COPD: ready for prime time Fernando J Martinez (USA) Is mild COPD worth treating? Fanny Ko (Hong Kong) Mechanisms of COPD exacerbations and their implications for treatment Sebastian Johnston (UK) | ||||
| CHANCELLOR ROOM | |||||
| 12:00 - 13:40 | Lunch symposium (sponsored by Novartis) Anti-IgE therapy in asthma Ratko Djukanovic (UK) Rationale for dual bronchodilator therapy in COPD Wisia Wedzicha (UK) | ||||
| MEETING ROOM S421 | |||||
| 13:45 - 15:15 | Symposium 5: Battle of the titans: where do we go from here? Inhaled steroid for COPD Pro: Neil Barnes (UK) Con: Peter Calverley (UK) Rebuttal Trait-directed treatment of airway disease Pro: Ian Pavord (UK) Con: Wisia Wedzicha (UK) Rebuttal Moving beyond disease labels in asthma & COPD - what are the research needs? Helen Reddel (Australia) | ||||
| 15:15 - 15:45 | Tea Break and Exhibition | ||||
| 15:45 - 17:15 | Symposium 6: Phenotype directed treatment of COPD Asthma-COPD overlap Jorgen Vestbo (UK) Eosinophilic COPD Ian Pavord (UK) Individualized care for our COPD patients Peter Calverley (UK) Endobronchial lung volume reduction for COPD Felix Herth (Germany) | ||||